Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 Jun;64(3):665–672.

Immunomodulating effect of low density lipoprotein on human monocytes.

G Paragh, J T Nagy, E Szondy, G Fóris, A Leövey
PMCID: PMC1542425  PMID: 3024882

Abstract

Low density lipoprotein (LDL) isolated from sera of healthy volunteers in 50 micrograms protein/ml concentration induced an early adenylate cyclase activation in human monocytes followed by elevation of cGMP level. In addition, a rapid 45Ca2+ influx was also detected on addition of 25-100 micrograms protein/ml concentrations. The monocyte activating effect of LDL under in vitro circumstances was characterized by an enhanced O2 consumption, H2O2 generation and by the increased release of lysosomal enzymes such as beta-glucuronidase and elastase like protease (ELP). On the other hand, LDL diminished markedly the Fc gamma receptor (Fc gamma R) mediated rosette formation, phagocytosis and the antibody dependent cellular cytotoxicity (ADCC) of monocytes without a significant decrease in the IgG binding capability of cells. High levels of serum LDL may play a significant role in the arterial wall injury by elastase like protease as well as biologically active oxygen species released from monocytes of patients suffering from arteriosclerosis.

Full text

PDF
665

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ager A., Gordon J. L. Differential effects of hydrogen peroxide on indices of endothelial cell function. J Exp Med. 1984 Feb 1;159(2):592–603. doi: 10.1084/jem.159.2.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Antonaci S., Jirillo E., Ventura M. T., Capurso A., Garofalo A. R., Bonomo L. In vitro effects of human lipoproteins on the immune system in healthy donors: inhibition of plaque forming cell generation and decreased frequency of NK cells. Clin Exp Immunol. 1984 Jun;56(3):677–682. [PMC free article] [PubMed] [Google Scholar]
  3. Aqel N. M., Ball R. Y., Waldmann H., Mitchinson M. J. Monocytic origin of foam cells in human atherosclerotic plaques. Atherosclerosis. 1984 Dec;53(3):265–271. doi: 10.1016/0021-9150(84)90127-8. [DOI] [PubMed] [Google Scholar]
  4. BAUMSTARK J. S., LAFFIN R. J., BARDAWIL W. A. A PREPARATIVE METHOD FOR THE SEPARATION OF 7S GAMMA GLOBULIN FROM HUMAN SERUM. Arch Biochem Biophys. 1964 Dec;108:514–522. doi: 10.1016/0003-9861(64)90436-9. [DOI] [PubMed] [Google Scholar]
  5. Bolton A. E., Hunter W. M. The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem J. 1973 Jul;133(3):529–539. doi: 10.1042/bj1330529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brittinger G., Hirschhorn R., Douglas S. D., Weissmann G. Studies on lysosomes. XI. Characterization of a hydrolase-rich fraction from human lymphocytes. J Cell Biol. 1968 May;37(2):394–411. doi: 10.1083/jcb.37.2.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brown M. S., Goldstein J. L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983;52:223–261. doi: 10.1146/annurev.bi.52.070183.001255. [DOI] [PubMed] [Google Scholar]
  8. Brown M. S., Goldstein J. L. Receptor-mediated endocytosis: insights from the lipoprotein receptor system. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3330–3337. doi: 10.1073/pnas.76.7.3330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. CORNWELL D. G., KRUGER F. A., HAMWI G. J., BROWN J. B. Studies on the characterization of human serum lipoproteins separated by ultracentrifugation in a density gradient. I. Serum lipoproteins in normal, hyperthyroid and hypercholesterolemic subjects. Am J Clin Nutr. 1961 Jan-Feb;9:24–40. doi: 10.1093/ajcn/9.1.24. [DOI] [PubMed] [Google Scholar]
  10. Cuthbert J. A., Lipsky P. E. Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism. J Clin Invest. 1984 Apr;73(4):992–1003. doi: 10.1172/JCI111325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. DIOGUARDI N., AGOSTONI A., FIORELLI G., LOMANTO B. Characterization of lactic dehydrogenase of normal human granulocytes. J Lab Clin Med. 1963 May;61:713–723. [PubMed] [Google Scholar]
  12. Dezsö B., Fóris G. Effect of angiotensin II on the Fc receptor activity of rat macrophages. Immunology. 1981 Feb;42(2):277–283. [PMC free article] [PubMed] [Google Scholar]
  13. Driscoll D. M., Getz G. S. Extrahepatic synthesis of apolipoprotein E. J Lipid Res. 1984 Dec 1;25(12):1368–1379. [PubMed] [Google Scholar]
  14. Evensen S. A., Galdal K. S., Nilsen E. LDL-induced cytotoxicity and its inhibition by anti-oxidant treatment in cultured human endothelial cells and fibroblasts. Atherosclerosis. 1983 Oct;49(1):23–30. doi: 10.1016/0021-9150(83)90004-7. [DOI] [PubMed] [Google Scholar]
  15. Fóris G., Gyimesi E., Komáromi I. The mechanism of antibody-dependent cellular cytotoxicity stimulation by somatostatin in rat peritoneal macrophages. Cell Immunol. 1985 Jan;90(1):217–225. doi: 10.1016/0008-8749(85)90183-2. [DOI] [PubMed] [Google Scholar]
  16. Goldstein J. L., Brown M. S. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974 Aug 25;249(16):5153–5162. [PubMed] [Google Scholar]
  17. Hornebeck W., Potazman J. P., De Cremoux H., Bellon G., Robert L. Elastase-type activity of human serum. Its variation in chronic obstructive lung diseases and atherosclerosis. Clin Physiol Biochem. 1983;1(6):285–292. [PubMed] [Google Scholar]
  18. Hui D. Y., Harmony J. A., Innerarity T. L., Mahley R. W. Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B. J Biol Chem. 1980 Dec 25;255(24):11775–11781. [PubMed] [Google Scholar]
  19. Johnston D., Robson J. M., Melnykovych G. Reduction in cell-associated low density lipoprotein in dexamethasone-treated HeLa cells: suggested mechanism. Endocrinology. 1983 Sep;113(3):907–914. doi: 10.1210/endo-113-3-907. [DOI] [PubMed] [Google Scholar]
  20. Kumagai K., Itoh K., Hinuma S., Tada M. Pretreatment of plastic Petri dishes with fetal calf serum. A simple method for macrophage isolation. J Immunol Methods. 1979;29(1):17–25. doi: 10.1016/0022-1759(79)90121-2. [DOI] [PubMed] [Google Scholar]
  21. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  22. Morel D. W., Hessler J. R., Chisolm G. M. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res. 1983 Aug;24(8):1070–1076. [PubMed] [Google Scholar]
  23. Morse J. H., Witte L. D., Goodman D. S. Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins. J Exp Med. 1977 Dec 1;146(6):1791–1803. doi: 10.1084/jem.146.6.1791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ogmundsdóttir H. M., Weir D. M. Mechanisms of macrophage activation. Clin Exp Immunol. 1980 May;40(2):223–234. [PMC free article] [PubMed] [Google Scholar]
  25. Pick E., Keisari Y. Superoxide anion and hydrogen peroxide production by chemically elicited peritoneal macrophages--induction by multiple nonphagocytic stimuli. Cell Immunol. 1981 Apr;59(2):301–318. doi: 10.1016/0008-8749(81)90411-1. [DOI] [PubMed] [Google Scholar]
  26. Schwartz S. M. Cellular proliferation in atherosclerosis and hypertension. Proc Soc Exp Biol Med. 1983 May;173(1):1–13. doi: 10.3181/00379727-173-41601. [DOI] [PubMed] [Google Scholar]
  27. Stabinsky Y., Bar-Shavit Z., Fridkin M., Goldman R. On the mechanism of action of the phagocytosis-stimulating peptide tuftsin. Mol Cell Biochem. 1980 Apr 18;30(2):71–77. doi: 10.1007/BF00227920. [DOI] [PubMed] [Google Scholar]
  28. Szondy E., Horváth M., Mezey Z., Székely J., Lengyel E., Füst G., Gerö S. Free and complexed anti-lipoprotein antibodies in vascular diseases. Atherosclerosis. 1983 Oct;49(1):69–77. doi: 10.1016/0021-9150(83)90008-4. [DOI] [PubMed] [Google Scholar]
  29. Takemura R., Werb Z. Modulation of apoprotein E secretion in response to receptor-mediated endocytosis in resident and inflammatory macrophages. J Exp Med. 1984 Jan 1;159(1):167–178. doi: 10.1084/jem.159.1.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tanabe A., Kobayashi Y., Usui T. Enhancement of human neutrophil oxygen consumption by chemotactic factors. Experientia. 1983 Jun 15;39(6):604–606. doi: 10.1007/BF01971119. [DOI] [PubMed] [Google Scholar]
  31. Traber M. G., Kallman B., Kayden H. J. Localization of the binding sites of native and acetylated low-density lipoprotein (LDL) in human monocyte-derived macrophages. Exp Cell Res. 1983 Oct 15;148(2):281–292. doi: 10.1016/0014-4827(83)90152-0. [DOI] [PubMed] [Google Scholar]
  32. Tsan M. F., Danis E. H., Del Vecchio P. J., Rosano C. L. Enhancement of intracellular glutathione protects endothelial cells against oxidant damage. Biochem Biophys Res Commun. 1985 Feb 28;127(1):270–276. doi: 10.1016/s0006-291x(85)80154-6. [DOI] [PubMed] [Google Scholar]
  33. Van Hinsbergh V. W. LDL cytotoxicity. The state of the art. Atherosclerosis. 1984 Nov;53(2):113–118. doi: 10.1016/0021-9150(84)90188-6. [DOI] [PubMed] [Google Scholar]
  34. Waelti E. R., Glueck R., Hess M. W. Modulation of concanavalin A-induced lymphocyte stimulation by human low-density lipoproteins. Eur J Immunol. 1981 Oct;11(10):846–848. doi: 10.1002/eji.1830111019. [DOI] [PubMed] [Google Scholar]
  35. Wang-Iverson P., Ginsberg H. N., Peteanu L. A., Le N. A., Brown W. V. Apo E-mediated uptake and degradation of normal very low density lipoproteins by human monocyte/macrophages: a saturable pathway distinct from the LDL receptor. Biochem Biophys Res Commun. 1985 Jan 16;126(1):578–586. doi: 10.1016/0006-291x(85)90645-x. [DOI] [PubMed] [Google Scholar]
  36. van Der Schroeff J. G., Havekes L., Emeis J. J., Wijsman M., van Der Meer H., Vermeer B. J. Morphological studies on the binding of low-density lipoproteins and acetylated low-density lipoproteins to the plasma membrane of cultured monocytes. Exp Cell Res. 1983 Apr 15;145(1):95–103. doi: 10.1016/s0014-4827(83)80012-3. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES